Apduhan, Claire B.

HRN: 27-28-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2025
AMPICILLIN 1GM (VIAL)
06/15/2025
06/17/2025
IV
2gms
Q6hrs
PROM X 8 Hrs
Waiting Final Action 
06/15/2025
CO-AMOXICLAV 625MG (TAB)
06/15/2025
06/21/2025
PO
625
BID
Prom X 18 Hrs
Waiting Final Action 
06/17/2025
CO-AMOXICLAV 625MG (TAB)
06/17/2025
06/24/2025
PO
625mg
BID
PROM
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: